20/20 BioLabs

Executive Summary

20/20 BioLabs (formerly 2020 GeneSystems) is a privately held diagnostics company headquartered in Durham, North Carolina, focused on developing AI-powered blood tests for the early detection and prevention of cancers and chronic diseases. The company leverages machine learning algorithms built on extensive real-world data to create laboratory-based diagnostics that offer exceptional accuracy and convenience. Founded in 2020, the company operates in the rapidly growing field of precision diagnostics, aiming to shift detection to earlier, more treatable stages.

Upcoming Catalysts (preview)

• Q4 2026Completion of clinical validation study for lead diagnostic test60% success
• Q3 2026Series A funding round40% success